GO:0001913 T cell mediated cytotoxicity: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001913 (T cell mediated cytotoxicity) describes the directed killing of a target cell by a T cell via granule release or death receptor engagement.
• Two principal effector routes exist: perforin/granzyme exocytosis and Fas/FasL-mediated apoptosis.
• Cytotoxic T lymphocytes (CTLs) and CD4 cytotoxic T cells can both mediate this process, with NKG2D contributing to CD4 CTL activity in multiple myeloma.
• In vivo dynamics of T cell cytotoxicity involve serial killing, rapid detachment, and tissue-specific regulation.
• Alternative splicing regulators such as CWF19L1 can promote T-cell cytotoxicity, linking RNA processing to effector function.
• Tumor microenvironment factors, including Aurora kinase activity, can modulate sensitivity to T-cell-mediated killing.
Description
T cell mediated cytotoxicity (GO:0001913) is a biological process in which a T cell directly kills a target cell through the release of cytotoxic granules or by engaging death receptors. This process is central to adaptive immunity against intracellular pathogens and tumors, and it is also implicated in autoimmune and inflammatory tissue damage. Understanding the molecular players and regulatory checkpoints of T cell mediated cytotoxicity is essential for designing immunotherapies, including bispecific antibodies and adoptive T cell therapies. The process is not a single event but a coordinated sequence of recognition, synapse formation, directed secretion, and target cell death. Recent work has expanded the known effector cell types and molecular regulators, showing that CD4 cytotoxic T cells can use NKG2D for cytotoxicity in multiple myeloma and that alternative splicing factors such as CWF19L1 can enhance T-cell cytotoxicity. These findings highlight the need for precise experimental models to dissect gene function in this pathway.
T cell mediated cytotoxicity At A Glance
| GO ID | GO:0001913 |
|---|---|
| GO term | T cell mediated cytotoxicity |
| Ontology | biological_process |
| Synonym | T cell mediated apoptosis; T-cell mediated cell death; T cell mediated cell killing; T cell mediated cytolysis; T lymphocyte mediated cytotoxicity |
| Major function | Directed killing of target cells by T cells via granule exocytosis or death receptor engagement |
| Key effector molecules | Perforin, granzymes, FasL, Fas, NKG2D |
| Cell types | Cytotoxic T lymphocytes (CTLs), CD4 cytotoxic T cells, T lymphocytes |
| Related processes | Apoptosis, immune synapse formation, granule exocytosis |
What Is GO:0001913?
GO:0001913 is defined as the directed killing of a target cell by a T cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors. In simpler terms, it is the process by which a T cell delivers a lethal hit to another cell, either by secreting cytotoxic proteins or by activating death receptors on the target cell surface.
Why Is T cell mediated cytotoxicity Important in Cell Biology?
T cell mediated cytotoxicity is a cornerstone of immune defense against viruses and tumors, and its dysregulation contributes to autoimmunity and inflammatory diseases. It is the mechanism underlying many immunotherapeutic strategies, including bispecific antibodies and checkpoint inhibitors, and it is a critical determinant of response to cancer immunotherapy. Understanding its molecular regulation can reveal biomarkers and targets for enhancing or dampening cytotoxic activity in disease.
• Essential for clearance of virus-infected cells and tumor cells.
• Mediates target cell apoptosis through perforin/granzyme and Fas/FasL pathways.
• Involved in autoimmune and inflammatory tissue damage, such as Lyme arthritis.
• Underlies the efficacy of T cell engager bispecific antibodies in cancer therapy.
• Modulated by tumor cell intrinsic factors, including Aurora kinase activity.
• Regulated by RNA splicing factors such as CWF19L1.
• CD4 cytotoxic T cells can contribute to cytotoxicity in multiple myeloma via NKG2D.
• In vivo dynamics include serial killing and rapid detachment from targets.
• Provides a functional readout for CRISPR screens targeting immune effector genes.
• Potential target for modulating graft-versus-host disease and transplant rejection.
What Happens During T cell mediated cytotoxicity?
Recognition and Immune Synapse Formation
In simple terms: The T cell first finds and tightly binds its target cell.
T cell mediated cytotoxicity begins with T cell receptor (TCR) recognition of peptide-MHC complexes on the target cell, leading to formation of a specialized contact zone called the immune synapse. This synapse organizes signaling molecules and cytoskeletal rearrangements that polarize the T cell toward the target. In CD4 cytotoxic T cells, NKG2D can also contribute to target recognition in contexts such as multiple myeloma.
Granule Exocytosis and Perforin/Granzyme Delivery
In simple terms: The T cell releases toxic granules that enter the target cell and trigger its death.
Upon activation, cytotoxic T lymphocytes release cytotoxic granules containing perforin and granzymes into the immune synapse. Perforin forms pores in the target cell membrane, allowing granzymes to enter and activate apoptotic pathways. This granule exocytosis pathway is a major mechanism of T cell mediated cytotoxicity.
Death Receptor Engagement (Fas/FasL)
In simple terms: The T cell can also kill by directly activating a death receptor on the target cell.
In addition to granule release, T cells can express Fas ligand (FasL) which engages Fas on target cells, triggering caspase-mediated apoptosis. This Fas-based pathway is a distinct route of T cell mediated cytotoxicity and can operate independently of perforin.
Target Cell Apoptosis and Detachment
In simple terms: The target cell dies, and the T cell moves on to kill again.
Following delivery of the lethal hit, target cells undergo apoptosis through caspase activation and mitochondrial changes. In vivo imaging has shown that cytotoxic T cells can detach from dying targets and serially kill multiple cells. This dynamic process is tightly regulated to avoid bystander damage.
Regulation by Alternative Splicing and Kinases
In simple terms: The killing process is tuned by intracellular signals and RNA processing.
Recent studies have identified regulators of T cell mediated cytotoxicity, including the splicing factor CWF19L1, which promotes T-cell cytotoxicity through regulation of alternative splicing. Aurora kinase inhibition can sensitize melanoma cells to T-cell-mediated cytotoxicity, indicating that target cell signaling modulates susceptibility to killing.
Key Genes Involved in GO:0001913 T cell mediated cytotoxicity
The following genes and proteins are central to T cell mediated cytotoxicity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRF1 | Perforin; forms pores in target cell membrane | Core effector of granule-mediated killing |
| GZMA | Granzyme A; serine protease in cytotoxic granules | Induces target cell apoptosis |
| GZMB | Granzyme B; serine protease in cytotoxic granules | Key mediator of caspase activation |
| FASLG | Fas ligand; engages Fas on target cells | Death receptor pathway of cytotoxicity |
| FAS | Death receptor on target cells | Mediates Fas-based apoptosis |
| KLRK1 | NKG2D; activating receptor on CD4 CTLs | Contributes to cytotoxicity in multiple myeloma |
| CD3E | TCR signaling component | Target for bispecific antibodies |
| CWF19L1 | Alternative splicing regulator | Promotes T-cell cytotoxicity |
| AURKA | Aurora kinase A; cell cycle regulator | Inhibition sensitizes melanoma to T-cell killing |
| CD8A | Co-receptor on cytotoxic T lymphocytes | Defines CTL subset |
| CD4 | Co-receptor on helper and cytotoxic T cells | Marks CD4 CTLs |
| IFNG | Interferon gamma; cytokine | Enhances antigen presentation and cytotoxicity |
| TNF | Tumor necrosis factor | Can induce target cell death |
| CASP3 | Executioner caspase | Mediates apoptosis downstream of granzymes |
| CASP8 | Initiator caspase | Mediates Fas-induced apoptosis |
| BID | BH3-interacting domain death agonist | Links granzyme B to mitochondrial apoptosis |
| ICAM1 | Adhesion molecule | Stabilizes immune synapse |
How Is T cell mediated cytotoxicity Regulated?
T cell mediated cytotoxicity is regulated at multiple levels. TCR signaling strength and co-stimulation determine the magnitude of the response. Cytokine signals such as IFN-gamma can modulate effector function. Intracellular regulators include alternative splicing factors like CWF19L1, which enhance cytotoxicity by regulating RNA processing. Target cell intrinsic pathways, such as Aurora kinase activity, can alter susceptibility to killing. In vivo, the process is dynamically controlled to allow serial killing while limiting collateral damage.
T cell mediated cytotoxicity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRF1 | Familial hemophagocytic lymphohistiocytosis | PRF1 knockout T cells |
| FAS | Autoimmune lymphoproliferative syndrome | FAS point mutation in target cells |
| KLRK1 | Multiple myeloma | NKG2D overexpression in CD4 T cells |
| CWF19L1 | Cancer immunotherapy response | CWF19L1 knockout in T cells |
| AURKA | Melanoma | AURKA inhibition in melanoma cells |
Cancer Immunotherapy
T cell mediated cytotoxicity is the primary mechanism by which immunotherapies eliminate tumor cells. Bispecific antibodies that engage CD3 on T cells and tumor antigens can induce cytotoxic activity, and cytokine release is not required for this effect. Aurora kinase inhibition can sensitize melanoma cells to T-cell-mediated cytotoxicity, suggesting combination strategies. In multiple myeloma, CD4 cytotoxic T cells can mediate NKG2D-dependent killing.
Autoimmunity and Inflammatory Diseases
Dysregulated T cell mediated cytotoxicity contributes to tissue damage in autoimmune and inflammatory conditions. In Lyme arthritis, cell-mediated cytotoxicity is observed and may contribute to joint inflammation. Fas-based cytotoxicity is implicated in autoimmune tissue destruction.
Infectious Disease
T cell mediated cytotoxicity is essential for controlling intracellular pathogens by killing infected cells. The process is a key component of antiviral immunity and is targeted by pathogens that evade immune recognition.
From T cell mediated cytotoxicity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate T cell cytotoxicity? | CRISPR knockout in primary T cells or Jurkat cells |
| Does a point mutation in FAS affect killing? | Point mutation knock-in in target cell lines |
| Can overexpression of NKG2D enhance CD4 CTL killing? | Knock-in overexpression in CD4 T cells |
| How does Aurora kinase inhibition affect sensitivity? | Pharmacological inhibition in melanoma cells |
| What is the role of splicing factor CWF19L1? | Knockout and rescue in T cells |
| Can bispecific antibodies induce cytotoxicity without cytokines? | In vitro cytotoxicity assays with CD3 bispecifics |
How to Study the T cell mediated cytotoxicity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Chromium release assay | Target cell lysis | Quantify CTL activity |
| Flow cytometry | Caspase activation, target death | Measure apoptosis |
| Live-cell imaging | Immune synapse dynamics | Study serial killing |
| RNA-seq | Gene expression changes | Identify regulators |
| CRISPR screen | Gene function in cytotoxicity | Discover novel targets |
| Western blot | Protein cleavage (e.g., caspase-3) | Confirm apoptosis |
| ELISA | Cytokine release | Assess T cell activation |
| Bispecific antibody assay | T cell-mediated killing | Therapeutic testing |
In Vitro Cytotoxicity Assays
Standard methods measure target cell killing by T cells using chromium release, flow cytometry, or luciferase-based assays. These assays quantify the efficiency of T cell mediated cytotoxicity and are used to test gene knockouts or drug treatments.
Live Imaging and Immune Synapse Analysis
Confocal and two-photon microscopy can visualize immune synapse formation, granule polarization, and serial killing in real time. These methods reveal dynamic interactions between T cells and targets.
Transcriptomics and Splicing Analysis
RNA-seq and alternative splicing analysis can identify regulators of cytotoxicity, such as CWF19L1. These approaches link gene expression changes to effector function.
CRISPR Screens
Genome-wide CRISPR knockout screens can identify genes that enhance or suppress T cell mediated cytotoxicity. Such screens are powerful for discovering novel regulators.
How CRISPR Can Be Used to Study GO:0001913 T cell mediated cytotoxicity
Knockout
CRISPR knockout of candidate genes in T cells or target cells can determine whether a gene is required for T cell mediated cytotoxicity. For example, knockout of CWF19L1 reduces cytotoxicity, demonstrating its role.
Point Mutation
Point mutations can model disease-associated variants in genes such as FAS to study their impact on death receptor-mediated killing. CRISPR point mutation knock-in allows precise editing of endogenous loci.
Knock-in
Knock-in of reporters or tags (e.g., fluorescent proteins) enables tracking of cytotoxic granule components or receptors like NKG2D. This helps visualize effector functions.
Overexpression
Overexpression of genes such as NKG2D in CD4 T cells can enhance cytotoxicity and is used to study gain-of-function effects. CRISPR activation or cDNA overexpression can achieve this.
How EDITGENE Supports T cell mediated cytotoxicity Research
Researchers studying T cell mediated cytotoxicity-related genes often need to determine whether a candidate gene is causally involved in the killing process or merely correlated with it. EDITGENE provides CRISPR-based services to enable such causal studies.
Contact EDITGENE today to design your custom CRISPR model for T cell mediated cytotoxicity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CTSH Knockout HEK293 Cell Line | EDJ-KQ2158 | Human | 1512 | Details Get a Quote |
| EMP2 Knockout HEK293 Cell Line | EDJ-KQ2529 | Human | 2013 | Details Get a Quote |
| CTSC Knockout HEK293 Cell Line | EDJ-KQ3284 | Human | 1075 | Details Get a Quote |
| CADM1 Knockout HEK293 Cell Line | EDJ-KQ3881 | Human | 23705 | Details Get a Quote |
| MICA Knockout HEK293 Cell Line | EDJ-KQ11941 | Human | 100507436 | Details Get a Quote |
| CRTAM Knockout HEK293 Cell Line | EDJ-KQ13007 | Human | 56253 | Details Get a Quote |
| HLA-A Knockout HEK293 Cell Line | EDJ-KQ13752 | Human | 3105 | Details Get a Quote |
| EMP2 Knockout HCT 116 Cell Line | EDJ-KQ23153 | Human | 2013 | Details Get a Quote |
| EMP2 Knockout HeLa Cell Line | EDJ-KQ23154 | Human | 2013 | Details Get a Quote |
| CADM1 Knockout A-549 Cell Line | EDJ-KQ26090 | Human | 23705 | Details Get a Quote |
| CADM1 Knockout HeLa Cell Line | EDJ-KQ26091 | Human | 23705 | Details Get a Quote |
| MICA Knockout HeLa Cell Line | EDJ-KQ39212 | Human | 100507436 | Details Get a Quote |
| EMP2 Knockout A-549 Cell Line | EDJ-KQ21791 | Human | 2013 | Details Get a Quote |
| CTSH Knockout A-549 Cell Line | EDJ-KQ22355 | Human | 1512 | Details Get a Quote |
| CTSH Knockout HCT 116 Cell Line | EDJ-KQ22356 | Human | 1512 | Details Get a Quote |
Displaying Records 1 To 15 Of 33 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About T cell mediated cytotoxicity
What is T cell mediated cytotoxicity?
T cell mediated cytotoxicity (GO:0001913) is the directed killing of a target cell by a T cell through the release of cytotoxic granules or engagement of death receptors.
What genes are involved in T cell mediated cytotoxicity?
Key genes include PRF1, GZMA, GZMB, FASLG, FAS, KLRK1, and CWF19L1.
What are the two main mechanisms of T cell mediated cytotoxicity?
The two main mechanisms are granule exocytosis (perforin/granzymes) and death receptor engagement (Fas/FasL).
How is T cell mediated cytotoxicity regulated?
It is regulated by TCR signaling, cytokines, alternative splicing factors like CWF19L1, and target cell intrinsic pathways such as Aurora kinases.
What diseases involve T cell mediated cytotoxicity?
It is involved in cancer immunotherapy, autoimmune diseases like Lyme arthritis, and infectious diseases.
How can I study T cell mediated cytotoxicity in the lab?
Common methods include chromium release assays, flow cytometry, live imaging, and CRISPR screens.
What is the role of perforin in T cell mediated cytotoxicity?
Perforin forms pores in the target cell membrane, allowing granzymes to enter and induce apoptosis.
Can CD4 T cells mediate cytotoxicity?
Yes, CD4 cytotoxic T cells can kill target cells, for example via NKG2D in multiple myeloma.
What is the role of Fas in T cell mediated cytotoxicity?
Fas is a death receptor that, when engaged by FasL on T cells, triggers apoptosis in target cells.
How do CRISPR screens help identify regulators of T cell cytotoxicity?
CRISPR screens can knockout genes genome-wide to discover factors like CWF19L1 that promote or inhibit cytotoxicity.
Conclusion
T cell mediated cytotoxicity (GO:0001913) is a vital immune process with broad implications for cancer, autoimmunity, and infectious disease. Its molecular mechanisms, including granule exocytosis and death receptor pathways, are well characterized, and recent studies continue to uncover new regulators such as CWF19L1 and NKG2D. CRISPR-based models are indispensable for dissecting gene function in this pathway and for developing new immunotherapies.
References
- 1. Berke G. 1991. T-cell-mediated cytotoxicity.. Curr Opin Immunol 3(3):320-5 PMID: 1910610
- 2. Kim S et al.. 2025. NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma.. Blood 146(4):456-470 PMID: 40106762
- 3. Ordóñez D et al.. 2023. Cell-Mediated Cytotoxicity in Lyme Arthritis.. Arthritis Rheumatol 75(5):782-793 PMID: 36413215
- 4. Halle S et al.. 2017. Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo.. Trends Immunol 38(6):432-443 PMID: 28499492
- 5. Golstein P. 1995. Fas-based T cell-mediated cytotoxicity.. Curr Top Microbiol Immunol 198:25-37 PMID: 7539731
- 6. Li J et al.. 2019. CD3 bispecific antibody-induced cytokine release is dispensable for cytotoxic T cell activity.. Sci Transl Med 11(508) PMID: 31484792
- 7. Zhang Y et al.. 2024. CWF19L1 promotes T-cell cytotoxicity through the regulation of alternative splicing.. J Biol Chem 300(12):107982 PMID: 39542248
- 8. Punt S et al.. 2021. Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity.. Cancer Immunol Immunother 70(4):1101-1113 PMID: 33123754
